Document is current
Any future updates will be listed below
-
Authors
Meyerson, Nicholas R.
Bauer, Vanessa L.
Fattor, Will T.
Warren, Cody J. https://orcid.org/0000-0003-4101-2705
Barbachano-Guerrero, Arturo https://orcid.org/0000-0001-7483-839X
Weiss, Melisa J.
Dirasantha, Obaiah
Burris, Bridget L.
Adesina, Adetunji S.
Timpona, Joseph L.
Feldman, Emily R.
Fahy, Ryan T.
Gendler, Paul https://orcid.org/0000-0002-2113-4564
Fainberg, Ava
Nehete, Pramod N.
Shelton, Kathryn A. https://orcid.org/0000-0002-1754-1423
Galvan, Analy
Tustin, George W.
Koehle, Paul J.
Salinas, Maria D.
Davila, Omar
Lindemann, Elizabeth I.
Clark, Sean E.
Garnett, Mackenzie L.
DeMarco, C. Todd
Scianna, Salvatore R.
Denny, Thomas N.
Kuhn, Jens H. https://orcid.org/0000-0002-7800-6045
Aye, Pyone P. https://orcid.org/0000-0002-4764-3965
Veazey, Ron S. https://orcid.org/0000-0002-6298-2391
Kezar, Sarah M. https://orcid.org/0000-0002-8423-0828
Wilkerson, Gregory K. https://orcid.org/0000-0002-3773-1064
Sawyer, Sara L. https://orcid.org/0000-0002-6965-1085
- License Information
-
More Information
Article History
Received: 31 July 2025
Accepted: 21 February 2026
First Online: 9 March 2026
Competing interests
: NRM, WTF, and SLS are employees of, or hold financial interests in, Darwin Biosciences in Boulder, CO, USA. The remaining authors declare no competing interests. A patent application is related to this work; PCT Application No. PCT/US2023/082939 for “Novel HIV-1 Variants and their Methods of Use in an Animal Challenge Model.”
